Comparison of the duration of action of ranibizumab and LAVA1 in the rabbit hVEGF-A 165 challenge model. Rabbit eyes were injected with 400 ng (10 pmoles) hVEGF-A 165 to induce retinal vascular permeability. Forty-eight hours later, fluorescein angiography was performed to measure the leakage of fluorescein from retinal vessels . Representative right and left eye images from two rabbits from each group are shown. Retinal vessels without leakage have fluorescence only inside the vessels due to labeling by high molecular weight fluorescein-dextran, while leaky blood vessels have fluorescein both within their lumens as well as diffusely outside. Ranibizumab inhibited retinal vascular leakage when dosed up to 9 days before fluorescein angiography but not when dosed 14 or 20 days before fluorescein angiography. In contrast, LAVA1 completely inhibited retinal vascular leakage for up to 30 days (longest time duration assessed).

